10.1152/ajprenal.00285.2007
10.1161/01.HYP.0000053448.95913.3D
10.1113/jphysiol.2005.084947
10.1152/ajpregu.00558.2006
10.1152/ajpendo.00004.2001
10.1113/jphysiol.2007.141580
Bridges JP, Gilbert JS, Colson D, Dukes M, Babcock SA, Ryan MJ, Granger JP.Soluble Flt-1 induces hypertension and vascular dysfunction in pregnant rats.FASEB J22: 969, 2008.
10.1017/S0007114507352392
10.1146/annurev.genom.6.080604.162350
Cox LA, Glenn J, Schiabritz-Loutsevitch NE, Nathanielsz PW, Nijland MJ.Sex effects of maternal nutrient restriction (MNR) on renal transcriptome expression in the 0.9 gestation (G) fetal baboon.Reprod Sci15: 120A, 2008.
10.1113/jphysiol.2006.106872
10.1093/oxfordjournals.humrep.a136581
10.1161/01.HYP.0000052949.85257.8E
10.1016/S0008-6363(01)00527-2
10.1016/j.ydbio.2003.12.018
10.1161/HYPERTENSIONAHA.107.100982
10.1152/ajpendo.00390.2006
Gilbert JS, Cox L, Babcock SA, Shade R, Nathanielsz PW, Nijland MJ.Gender-specific effects of moderate maternal nutrient restriction (NR) in the first half of pregnancy on fetal renal renin-angiotensin system (RAS).J Soc Gynecol Investig13: 207A, 2006.
10.1203/01.pdr.0000250208.09874.91
10.1113/jphysiol.2005.084202
10.1161/HYPERTENSIONAHA.107.096594
10.1016/j.genm.2008.03.012
10.1152/ajpregu.00725.2006
Gubhaju L, Nathanielsz PW, Nyengaard JR, Nijland MJ, Black MJ.Effects of a thirty percent global reduction in maternal nutrient intake on development of the fetal baboon kidney at term.Early Hum Dev83: S166–S167, 2007.
10.1002/(SICI)1098-2795(200002)55:2<146::AID-MRD3>3.0.CO;2-F
10.1053/j.ajkd.2007.09.013
10.1016/0002-9378(89)90924-1
Haris RC.Cyclooxygenase-2 in the Kidney.J Am Soc Nephrol11: 2387–2394, 2000.
10.1095/biolreprod.104.035675
10.1203/00006450-200208000-00020
10.1016/S1046-2023(02)00072-5
10.1152/ajpregu.00442.2006
10.1161/01.HYP.0000257196.13485.9b
10.1007/s10545-006-0299-7
10.1053/j.ajkd.2007.06.015
10.1111/j.0009-9163.2004.00236.x
10.1152/ajpregu.00354.2004
10.1161/01.HYP.0000047511.97879.FC
Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP.Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension.Development127: 4195–4202, 2000.
10.1001/archinte.160.10.1472
10.1016/0300-9629(96)00018-7
10.1161/01.CIR.0000145165.80130.B5
Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C, McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ.Low birth weight is associated with chronic kidney disease only in men.Kidney Int73: 637–642, 2007.
Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC.Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring.Br J Nutr100: 278–282, 2008.
10.1017/S000711450769196X
10.1152/ajpregu.00191.2007
10.1152/ajprenal.00066.2007
Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, Hankins GD, Longo M, Saade GR.Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life.Am J Obstet Gynecol197: 418–5, 2007.
Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, Hankins GDV, Saade GR.The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice [Online].Am J Obstet Gynecol196: 396, 2007.
10.1152/physrev.00053.2003
10.1161/01.HYP.0000188702.96256.46
10.1152/ajpregu.00523.2002
10.1046/j.1523-1755.1999.00260.x
10.1152/ajprenal.00383.2002
10.1053/j.ackd.2008.01.001
10.1161/HYPERTENSIONAHA.107.091785
10.1152/ajpheart.00718.2006
10.1161/01.HYP.0000049763.51269.51
10.1111/j.1469-7793.2001.0141m.x
10.1016/S0960-9822(95)00207-7
10.1016/0002-9378(84)90255-2
10.1152/ajpregu.00887.2006
10.1161/01.ATV.0000186185.13977.94
10.1111/j.1558-5646.1984.tb00346.x
10.1016/j.devcel.2004.05.005
10.1016/j.tig.2005.03.005
10.1152/ajpregu.00424.2006
10.1161/HYPERTENSIONAHA.107.087957
10.1161/HYPERTENSIONAHA.107.100750
10.1161/HYPERTENSIONAHA.107.101477
10.1016/S1550-8579(08)80003-4
10.1016/j.cardiores.2004.01.020
10.1097/00005237-199812000-00005
10.1152/ajpregu.00429.2007
10.1152/ajpregu.00864.2007
10.1136/bmj.326.7401.1245
10.1113/jphysiol.2002.018879
10.1016/S0092-8674(00)81444-0
10.1097/00004872-200412000-00011
10.1146/annurev.nutr.27.061406.093705
10.1016/0895-7061(95)00216-2
10.1161/01.CIR.0000089505.34741.E5
10.1152/ajpregu.1999.276.4.R974
10.1203/00006450-200104000-00005
10.1152/ajpregu.1998.275.5.R1593
10.1152/ajpregu.00037.2003
10.1095/biolreprod66.1.127
10.1161/HYPERTENSIONAHA.107.091603
10.1152/ajpcell.00296.2004
10.1093/oxfordjournals.aje.a116817
10.1016/S0168-9525(01)02446-5